Literature DB >> 21871215

Secondary transmissions during the outbreak of Shiga toxin-producing Escherichia coli O104 in Hesse, Germany, 2011.

Am Hauri1, U Gotsch, I Strotmann, J Krahn, G Bettge-Weller, Hj Westbrock, O Bellinger, H Uphoff.   

Abstract

During the recent outbreak of Shiga toxin-producing Escherichia coli (STEC) O104:H4 in Germany most cases notified in the State of Hesse (6 million inhabitants) were linked to satellite clusters or had travelled to the outbreak area in northern Germany. Intensified surveillance was introduced to rapidly identify cases not linked to known clusters or cases and thus to obtain timely information on possible further contaminated vehicles distributed in Hesse, as well to describe the risk of secondary transmission among known cases. As of 2 August 2011* [corrected], 56 cases of haemolytic uraemic syndrome (HUS) including two fatal cases, and 124 cases of STEC gastroenteritis meeting the national case definitions have been reported in Hesse. Among the 55 HUS and 81 STEC gastroenteritis cases thatmet the outbreak case definition, one HUS case and eight STEC gastroenteritis cases may have acquired their infection through secondary transmission. They include six possible transmissions within the family, two possible nosocomial and one possible laboratory transmission. Our results do not suggest an increased transmissibility of the outbreak strain compared to what is already known about E. coli O157 and other STEC serotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21871215

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  8 in total

Review 1.  Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology.

Authors:  Maite Muniesa; Jens A Hammerl; Stefan Hertwig; Bernd Appel; Harald Brüssow
Journal:  Appl Environ Microbiol       Date:  2012-04-13       Impact factor: 4.792

2.  [Current detection rates of multiresistant gram negative bacteria (3MRGN, 4MRGN) in patients with chronic leg ulcers].

Authors:  F Jockenhöfer; H Gollnick; K Herberger; G Isbary; R Renner; M Stücker; E Valesky; U Wollina; M Weichenthal; S Karrer; B Ross; E Heintschel von Heinegg; J Dissemond
Journal:  Hautarzt       Date:  2014-11       Impact factor: 0.751

3.  Fitness of Enterohemorrhagic Escherichia coli (EHEC)/Enteroaggregative E. coli O104:H4 in Comparison to That of EHEC O157: Survival Studies in Food and In Vitro.

Authors:  Christina Böhnlein; Jan Kabisch; Diana Meske; Charles M A P Franz; Rohtraud Pichner
Journal:  Appl Environ Microbiol       Date:  2016-10-14       Impact factor: 4.792

Review 4.  Outbreaks of virulent diarrheagenic Escherichia coli--are we in control?

Authors:  Dirk Werber; Gérard Krause; Christina Frank; Angelika Fruth; Antje Flieger; Martin Mielke; Lars Schaade; Klaus Stark
Journal:  BMC Med       Date:  2012-02-02       Impact factor: 8.775

Review 5.  Public Health Research Resulting from One of the World's Largest Outbreaks Caused by Entero-Hemorrhagic Escherichia coli in Germany 2011: A Review.

Authors:  Elena Köckerling; Laura Karrasch; Aparna Schweitzer; Oliver Razum; Gérard Krause
Journal:  Front Public Health       Date:  2017-12-11

6.  Epidemiological and Ecological Characterization of the EHEC O104:H4 Outbreak in Hamburg, Germany, 2011.

Authors:  Maike Tahden; Juliane Manitz; Klaus Baumgardt; Gerhard Fell; Thomas Kneib; Guido Hegasy
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

7.  A registry-based study of non-Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantation.

Authors:  M L Fox; P Barba; I Heras; M López-Parra; M González-Vicent; R de la Cámara; M Batlle; R Parody; C Vallejo; I Ruiz-Camps; L Vázquez
Journal:  Clin Microbiol Infect       Date:  2014-10-13       Impact factor: 8.067

8.  Transmission of shiga toxin-producing Escherichia coli O104:H4 at a family party possibly due to contamination by a food handler, Germany 2011.

Authors:  M Diercke; M Kirchner; K Claussen; E Mayr; I Strotmann; J Frangenberg; A Schiffmann; G Bettge-Weller; M Arvand; H Uphoff
Journal:  Epidemiol Infect       Date:  2013-04-08       Impact factor: 4.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.